A large study supports the use of stereotactic radiosurgery in patients with 15 or more brain metastases, finding improved ...

Penny stocks are on the riskier end of the public equity spectrum. They are characterized by their low volume, affordable ...

The 12-month BCM Stereotactic and Functional Fellowship provides an intensive surgical experience in all areas of adult and pediatric functional neurosurgery, combined with collaborative training with ...

ClearPoint Neuro (Nasdaq:CLPT) announced today that the FDA granted 510(k) clearance for its Prism bone anchor accessory.

Stereotactic radiosurgery (SRS) sends narrow beams of radiation into your cancer. The beams can focus on a tumor of any size or shape. It causes little damage to nearby healthy cells. If you have only ...

Stereotactic body radiotherapy (SBRT) also known as stereotactic ablative radiotherapy (SABR) is a precise, painless, non-invasive radiation treatment that utilizes very accurately targeted, large ...

Future Oncol. 2010;6(2):305-317. While the role of PET/CT in external beam radiotherapy has been evaluated, to date, no studies have evaluated its role in SBRT. A Phase I trial from our ...

Q3 2024 Earnings Call Transcript May 1, 2024 Accuray Incorporated misses on earnings expectations. Reported EPS is $-0.06 EPS ...

ClearPoint Neuro, Inc. (Nasdaq: CLPT) (the “Company”), a global device, cell, and gene therapy-enabling company offering precise navigation to the brain and spine, today announced it has initiated the ...

Prostate cancer is the most common cancer diagnosed in men, and the five year survival rate is 97%.

Similar to the recent launch of our SmartFrame OR platform, the introduction of the Prism Bone Anchor Accessory for use with the ClearPoint Prism Neuro Laser Therapy System supports our continued ...

“We estimate that more than 95% of all stereotactic neuro-navigation procedures take place in the OR, supporting DBS, Laser Ablation, Biopsy, sEEG, and more. This product is the first in ...